Kombucha in Overweight and Obese: Live Vs. Pasteurized Effects on Microbiota, Metabolism, and Liver Function
In plain words A study of kombucha in people 18 to 60, run by Associação Centro de Apoio Tecnológico Agro Alimentar. It plans to enroll about 33 people at 2 sites, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 60. Conditions: Obesity and Overweight.
What it tests, as registered
Live kombucha (non filtered/ non pasteurized); Pasteurized kombucha (non filtered); Control (sparkling water)
Registered summary
Kombucha, a fermented beverage made from Camellia sinensis tea (black, oolong, or green) with sugar and a symbiotic culture of bacteria and yeast (SCOBY), has gained global attention for its potential health benefits. Factors like the type and amount of sugar substrate, fermentation time, and temperature significantly influence its organic compounds, total phenolics, vitamin content, and alcohol levels. In a previous study, kombucha's impact on glucose tolerance, insulin sensitivity, body composition, and liver function was tested in male prediabetic mice with diet-induced obesity. The full summary is on the listing.
Where, as registered
No US site; Portugal (2).